Ligence Heart vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department aims to significantly streamline and enhance the accuracy of 2D transthoracic echocardiography analysis and reporting. This tool is ideal for clinics and hospitals looking to automate measurements, view classification, and report generation directly from PACS, thereby improving diagnostic efficiency for cardiologists and sonographers.
View Ligence Heart →Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II Insertable Cardiac Monitor if you require long-term, continuous heart rhythm monitoring for patients with suspected infrequent or paroxysmal arrhythmias. This device is best suited for identifying elusive arrhythmias over an extended period, offering AI-powered accuracy, remote management capabilities, and MRI compatibility for comprehensive patient care.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Ligence Heart | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Contact-for-pricing | Unknown |
| Deployment | Cloud-based; on-premise; hybrid | Subcutaneous implant with remote monitoring via mobile app or home communicator. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartLigence Heart is a web-based platform designed to automate and streamline the analysis and reporting of echocardiography, directly reducing manual workload and clicks for cardiologists and sonographers. Its intuitive interface and seamless integration with existing PACS, EHR, and RIS systems enhance the daily workflow for clinicians.
Clinical Value
TieBoth tools offer significant clinical value in their respective domains. Ligence Heart enhances diagnostic efficiency and accuracy for structural heart diseases, with studies showing strong agreement with gold standards and even AI outperforming human measurements in some aspects. LINQ II provides superior, long-term, and highly accurate arrhythmia detection, significantly reducing false positives and improving patient management, with clear evidence of outperforming consumer wearables.
Pricing & Value
LINQ II Insertable Cardiac MonitorWhile both tools have non-transparent, enterprise-negotiated pricing, Medtronic LINQ II has published cost-effectiveness data. Studies demonstrate its value in reducing strokes and improving quality-adjusted life years, providing a strong argument for its economic value proposition.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic LINQ II benefits from being part of Medtronic, a global medical technology giant founded in 1949, with over a million patients served and a leading market share in insertable cardiac monitors. This demonstrates superior enterprise readiness due to its immense scale, established global infrastructure, and long-standing presence in healthcare systems worldwide.
Innovation
Ligence HeartLigence Heart's innovation lies in its comprehensive AI-driven automation of the entire 2D transthoracic echocardiography analysis workflow, a complex and traditionally manual diagnostic process. This includes automated measurements, view classification, and disease recognition, with evidence of AI surpassing human performance in some measurements, representing a disruptive innovation in diagnostic imaging.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic, as a large and established global company, offers a more robust and multi-faceted support system, including dedicated technical and patient services via phone, and extensive online resources with clinician manuals and clinical evidence. Ligence Heart provides clear email contacts and online user manuals, but Medtronic's scale implies broader and more comprehensive support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Ligence Heart | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Product Name | Ligence Heart | LINQ II Insertable Cardiac Monitor |
| Company | Ligence | Medtronic |
| Description/Type of Tool | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography. | Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring. |
| Primary AI Function/Key Feature | Automated recognition of echocardiography imaging data, view classification, heart phase prediction, measurements, and report generation. | AccuRhythmu2122 AI algorithms for enhanced accuracy in diagnosing arrhythmias; innovative PVC detection algorithm. |
| Specialties | Cardiology | Cardiology |
| Additional Compliance/Offering | Has BAA: Yes | Free Trial: No |
Videos
Demos, reviews, and walkthroughs featuring Ligence Heart and LINQ II Insertable Cardiac Monitor.